Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Meta-analysis of low-molecular-weight heparin (LMWH) trials in unstable angina/non–ST-segment elevation myocardial infarction: ESSENCE, Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events; FRAXIS = FRAXiparine in Ischemic Syndromes; FRIC = FRagmin In unstable Coronary artery disease; LMWH = low-molecular-weight heparin; RRR = relative risk ratio; TIMI = Thrombolysis in Myocardial Infarction; UFH = unfractionated heparin. Adapted from Semin Thromb Hemost 1999;25 Suppl 3:113–21 (Fig. 3), with permission from Thieme Publishers, 2002.
|
